Company / Operating Cash Flow
Vanda Pharmaceuticals Inc. Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$12.8M
FY2025
5-year range
$12.8M / $64.2M
FY2021-FY2025
Trend
-60.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has fluctuated over the past 10 years, ranging from -$82M in FY2016 to $64M in FY2023.
Based on SEC 10-K filings.
$13M in FY2025 with a 5-year CAGR of -15.7%.
Declined from $64M to $13M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -37.2%
- 5-Year CAGR
- -15.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -15.7%, indicating a declining trend.
- In FY2025, operating cash flow decreased 60.0% year-over-year.
- Peak operating cash flow was recorded in FY2023.
- Lowest operating cash flow in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -3.96 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.8M | -60.0% |
| FY2024 | $32.0M | -50.2% |
| FY2023 | $64.2M | +24.0% |
| FY2022 | $51.8M | +12.7% |
| FY2021 | $45.9M | +53.2% |
| FY2020 | $30.0M | +1612.2% |
| FY2019 | -$2.0M | +75.5% |
| FY2018 | -$8.1M | -165.1% |
| FY2017 | $12.4M | +115.3% |
| FY2016 | -$81.6M | -106.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026